A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

Clinical trial NCT05904470 · COMPLETED

Trial details

NCT number: NCT05904470
Sponsor: Atea Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C Virus Hepatitis C, Chronic Hepatitis C Hepatic Cirrhosis HCV

Start date: 2023-05-30
Primary completion: 2024-12-09
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.